abstract |
The present invention relates to a method for diagnosing a tumor in a patient said method comprising measuring the concentration of Progesterone-Induced Immunomodulatory Protein (PIBF) or a derivative thereof or a fragment thereof in the sample taken from the patient, and to the use of an anti-PIBF or a derivative thereof or a fragment thereof, and a polynucleotide endoding PIBF, respectively, as an anti-tumor medicine. |